X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (74) 74
oncology (68) 68
female (57) 57
aged (55) 55
male (53) 53
index medicus (51) 51
middle aged (51) 51
chemotherapy (42) 42
adult (40) 40
lung neoplasms - drug therapy (37) 37
antineoplastic combined chemotherapy protocols - therapeutic use (35) 35
carcinoma, non-small-cell lung - drug therapy (34) 34
aged, 80 and over (31) 31
treatment outcome (31) 31
survival (23) 23
carcinoma, non-small-cell lung - genetics (22) 22
deoxycytidine - administration & dosage (21) 21
deoxycytidine - analogs & derivatives (21) 21
lung neoplasms - genetics (21) 21
respiratory system (20) 20
cancer (18) 18
lung neoplasms - pathology (18) 18
antineoplastic combined chemotherapy protocols - adverse effects (17) 17
carcinoma, non-small-cell lung - pathology (17) 17
disease-free survival (17) 17
mutation (16) 16
prognosis (16) 16
neoplasm staging (15) 15
lung cancer (14) 14
neoplasm metastasis (14) 14
cisplatin (13) 13
colorectal neoplasms - drug therapy (13) 13
gefitinib (13) 13
hematology, oncology and palliative medicine (13) 13
colorectal neoplasms - pathology (12) 12
fluorouracil - administration & dosage (12) 12
receptor, epidermal growth factor - genetics (12) 12
survival analysis (12) 12
antineoplastic agents - therapeutic use (11) 11
care and treatment (11) 11
cisplatin - administration & dosage (11) 11
organoplatinum compounds - administration & dosage (11) 11
capecitabine (10) 10
disease progression (10) 10
leucovorin (10) 10
lung cancer, non-small cell (10) 10
metastasis (10) 10
non-small-cell lung cancer (10) 10
oxaliplatin (10) 10
trial (10) 10
adenocarcinoma (9) 9
antineoplastic combined chemotherapy protocols - administration & dosage (9) 9
carcinoma (9) 9
colorectal cancer (9) 9
irinotecan (9) 9
kaplan-meier estimate (9) 9
lung neoplasms - mortality (9) 9
non-small cell lung cancer (9) 9
protein kinase inhibitors - therapeutic use (9) 9
pulmonary/respiratory (9) 9
taxoids - administration & dosage (9) 9
therapy (9) 9
bevacizumab (8) 8
brca1 (8) 8
carcinoma, non-small-cell lung - mortality (8) 8
combination (8) 8
drug administration schedule (8) 8
fluorouracil (8) 8
fluorouracil - analogs & derivatives (8) 8
messenger-rna expression (8) 8
prospective studies (8) 8
quinazolines - therapeutic use (8) 8
spain (8) 8
brca1 protein - genetics (7) 7
cetuximab (7) 7
clinical trials (7) 7
egfr mutations (7) 7
erlotinib (7) 7
erlotinib hydrochloride (7) 7
genetic aspects (7) 7
health aspects (7) 7
medicine & public health (7) 7
nsclc (7) 7
open-label (7) 7
phase-iii (7) 7
receptor, epidermal growth factor - antagonists & inhibitors (7) 7
research (7) 7
survival rate (7) 7
1st-line treatment (6) 6
camptothecin - administration & dosage (6) 6
camptothecin - analogs & derivatives (6) 6
cancer patients (6) 6
cancer research (6) 6
carboplatin - administration & dosage (6) 6
combined modality therapy (6) 6
deoxycytidine - adverse effects (6) 6
docetaxel (6) 6
expression (6) 6
gemcitabine (6) 6
metastases (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


British journal of cancer, ISSN 0007-0920, 09/2016, Volume 115, Issue 7, pp. 789 - 796
Journal Article
Journal of Thoracic Oncology, ISSN 1556-0864, 02/2019, Volume 14, Issue 2, pp. 304 - 310
Partner and localizer of BRCA2 (PALB2) is essential for homologous recombination repair. We examined mRNA levels of DNA repair genes, including partner and... 
RNA expression | Non–small cell lung cancer | PALB2 | Docetaxel | ONCOLOGY | RESPIRATORY SYSTEM | Non-small cell lung cancer | BRCA1
Journal Article
JOURNAL OF THORACIC ONCOLOGY, ISSN 1556-0864, 12/2019, Volume 14, Issue 12, pp. 2120 - 2132
Introduction: The ROS1 gene rearrangement has become an important biomarker in NSCLC. The College of American Pathologists/International Association for the... 
Immunohistochemistry | CANCER PATIENTS | ALK | MULTICENTER | TRANSLOCATIONS | ADENOCARCINOMA | Lung carcinoma | Next-generation sequencing | ONCOLOGY | RESPIRATORY SYSTEM | FISH | CRIZOTINIB | FUSIONS | SELECTION | ROS1 | EXPRESSION
Journal Article
Journal Article
Translational Lung Cancer Research, ISSN 2218-6751, 2013, Volume 2, Issue 3, pp. 208 - 221
Lung cancer accounts for the majority of cancer-related deaths worldwide. At present, platinum-based therapy represents the standard of care in fit stage II... 
Biomarkers | Individualized therapy | Adjuvant therapy | Non-small cell lung cancer | adjuvant therapy | Review | biomarkers | individualized therapy
Journal Article
Clinical Colorectal Cancer, ISSN 1533-0028, 2012, Volume 11, Issue 3, pp. 200 - 206
Journal Article
by Emile, Jean-François and Julié, Catherine and Le Malicot, Karine and Lepage, Come and Tabernero, Josep and Mini, Enrico and Folprecht, Gunnar and Van Laethem, Jean-Luc and Dimet, Stéphanie and Boulagnon-Rombi, Camille and Allard, Marc-Antoine and Penault-Llorca, Frédérique and Bennouna, Jaafar and Laurent-Puig, Pierre and Taieb, Julien and Thaler, Josef and Greil, Richard and Gaenzer, Johannes and Eisterer, Wolfgang and Tschmelitsch, Joerg and Keil, Felix and Samonigg, Hellmut and Zabernigg, August and Schmid, Franz and Steger, Günther and Steinacher, Robert and Andel, Johannes and Jagdt, Björn and Lang, Alois and Fridrik, Michael and Függer, Reinhold and Hofbauer, Friedrich and Woell, Ewald and Geissler, Dietmar and Lenauer, Alfred and Prager, Manfred and D'Haens, Geert and Demolin, Gauthier and Kerger, Joseph and Deboever, Guido and Ghillebert, Gilbert and Polus, Marc and Van Cutsem, Eric and Kalantari, Hassan Rezaie and Delaunoit, Thierry and Goeminne, Jean Charles and Peeters, Marc and Vergauwe, Philippe and Houbiers, Ghislain and Humblet, Yves and Janssens, Jos and Schrijvers, Dirk and Vanderstraeten, Erik and Van Laethem, Jean-Luc and Vermorken, Jan and Van Daele, Daniel and Ferrante, Michel and Forget, Frederic and Hendlisz, Alain and Yilmaz, Mette and Nielsen, Svend Erik and Vestermark, Lene and Larsen, Jim and Zawadi, Mohamed-Ayman and Bouche, Olivier and Mineur, Laurent and Bennouna-Louridi, Jaafar and Dourthe, Louis Marie and Ychou, Marc and Boucher, Eveline and Taieb, Julien and Pezet, Denis and Desseigne, Francoise and Ducreux, Michel and Texereau, Patrick and Miglianico, Laurent and Rougier, Philippe and Fratte, Serge and Levache, Charles-Briac and Merrouche, Yacine and Ellis, Stephen and Locher, Christophe and Ramee, Jean-Francois and Garnier, Claire and Viret, Frederic and Chauffert, Bruno and Cojean-Zelek, Isabelle and Michel, Pierre and Lecaille, Cedric and Borel, Christian and Seitz, Jean-Francois and Smith, Denis and Lombard-Bohas, Catherine and Andre, Thierry and Gornet, Jean-Marc and Fein, Francine and Coulon-Sfairi, Marie-Aude and Kaminsky, Marie-Christine and Lagasse, Jean-Paul and Luet, Dominique and ... and Istituto Oncologico Romagnolo (IOR) and Fédération Nationale des Centres de Lutte Contre le Cancer Association Européenne de Recherche en Oncologie (AERO) and Gruppo Cooperativo do Cancro Digestivo da Associação Portuguesa de Investigação Oncológica (GCCD, APIO) and Lone Nørgård Petersen and Gruppo Italiano per lo Studio dei Carcinomi dell'Apparato Digerente (GISCAD) and the PETACC8 Study Investigators and Austrian Breast and Colorectal cancer Study Group (ABCSG) and Belgian Group of Digestive Oncology (BGDO) and Gruppo Cooperativo Chirurgico Italiano (GOCCI) and John Allen Bridgewater and Gruppo Oncologico dell'Italia Meridionale (GOIM) and Fédération Francophone de Cancérologie Digestive (FFCD) and Gruppo Oncologico Nord Ovest (GONO) and Fédération Nationale des Centres de Lutte Contre le Cancer (UNICANCER) and Grupo Español para el Tratamiento de los Tumores Digestivos (TTD) and Arbeitsgemeinschaft Internistische Onkologie (AIO) and Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC) and PETACC8 Study Investigators
European Journal of Cancer, ISSN 0959-8049, 09/2017, Volume 82, pp. 16 - 24
Journal Article
Oncotarget, ISSN 1949-2553, 2018, Volume 9, Issue 1, pp. 488 - 494
Background: Circulating tumor DNA (ctDNA) levels correlate well with tumor bulk. In this paper we aim to estimate the prognostic value of the dynamic... 
Tyrosine kinase inhibitor | ctDNA | EGFR | Non-small cell lung cancer | non-small cell lung cancer | SURVIVAL | PLASMA DNA | EGFR MUTATIONS | T790M | CELL BIOLOGY | BREAST-CANCER | CIRCULATING TUMOR DNA | RESISTANCE | tyrosine kinase inhibitor | OUTCOMES | NSCLC PATIENTS | ERLOTINIB
Journal Article
Lung Cancer, ISSN 0169-5002, 2013, Volume 81, Issue 1, pp. 84 - 90
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.